MEIS1 and neuroblastoma: Variants in LMO1 have been associated with BMI44 and neuroblastoma and T-cell leukemia45,46, which is of interest since the strongest genetic predictor for RLS is a variant in MEIS1 that affects cancers such as leukemia and neuroblastoma47–49.